From: Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study
Estimate | p value | Translation* | |
---|---|---|---|
Baseline A1C | 0.06050 | <0.0001 | |
Month (0 – 24) | <0.0001 | ||
Insurance | 0.003 | ||
Uninsured | 0.02198 | 0.06 | 5.2% increase in A1C 1 |
County Medical Services (MIA) | -0.01300 | 0.20 | |
Insured (ref) | - | - | |
Diabetes duration | <0.0001 | ||
> 10 years | 0.06169 | <0.0001 | 15.3% increase in A1C |
6 – 10 years | 0.03555 | 0.008 | 8.5% increase in A1C |
1 – 5.9 years | 0.03253 | 0.003 | 7.8% increase in A1C |
< 1 year (ref) | - | - | |
Medicine | <0.0001 | ||
Insulin alone or insulin + oral agents | 0.08768 | <0.0001 | 22.4% increase in A1C |
> 1 oral agent (no insulin) | 0.04930 | <0.0001 | 12.0% increase in A1C |
No medicine or 1 oral agent (ref) | - | - | |
Total cholesterol (0.65 mmol/l (25 mg/dl) interval) | 0.01115 | <0.001 | 2.6% increase in A1C |
Age * month | <0.001 |